Insider Trading activities at Relay Therapeutics, Inc. (RLAY) , Part 2

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Relay Therapeutics, Inc. (RLAY) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Relay Therapeutics, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1812364.

Total stock buying since 2020: $2,200,000.
Total stock sales since 2020: $271,496,182.
Total stock option exercises since 2020: $4,842,757.


 1   2 
10 insiders reported insider trading activities at Relay Therapeutics, Inc. (RLAY):
Insider trading activities of Patel Sanjiv
Insider trading activities of Murcko Mark
Insider trading activities of Ingram Douglas S
Insider trading activities of Rahmer Peter
Insider trading activities of Porter Andy
Insider trading activities of Catinazzo Thomas
Insider trading activities of Adams Brian
Insider trading activities of Rubin Jami
Insider trading activities of Trv Gp Iv, Llc
Insider trading activities of Bergstrom Donald A

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Relay Therapeutics, Inc. (RLAY).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2026 0 $0 564,370 $8,881,908 264,702 $1,225,227
2025 0 $0 1,483,237 $6,470,513 0 $0
2024 0 $0 373,135 $2,633,470 128,948 $649,897
2023 0 $0 155,109 $2,928,535 126,000 $635,040
2022 0 $0 447,764 $11,642,284 393,543 $1,660,036
2021 0 $0 5,819,343 $238,939,472 163,242 $672,557
2020 110,000 $2,200,000 0 $0 0 $0


Table 3. Detailed insider trading at Relay Therapeutics, Inc. (RLAY) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2022-12-27 Adams Brian (Chief Legal Officer) Sale 295 14.49 4,274
2022-11-10 Patel Sanjiv (President and CEO) Sale 28,000 20.00 560,000
2022-11-10 Patel Sanjiv (President and CEO) Option Ex 28,000 4.58 128,240
2022-11-08 Patel Sanjiv (President and CEO) Sale 14,000 20.18 282,520
2022-11-08 Patel Sanjiv (President and CEO) Option Ex 14,000 4.12 57,680
2022-10-13 Patel Sanjiv (President and CEO) Sale 14,000 20.58 288,120
2022-10-13 Patel Sanjiv (President and CEO) Option Ex 14,000 4.12 57,680
2022-10-12 Patel Sanjiv (President and CEO) Sale 14,000 21.18 296,520
2022-10-12 Patel Sanjiv (President and CEO) Option Ex 14,000 4.12 57,680
2022-10-11 Patel Sanjiv (President and CEO) Sale 14,000 21.36 299,040
2022-10-11 Patel Sanjiv (President and CEO) Option Ex 14,000 4.12 57,680
2022-09-27 Porter Andy (Chief Administrative Officer) Sale 259 22.73 5,887
2022-09-27 Catinazzo Thomas (Chief Financial Officer) Sale 443 22.73 10,069
2022-09-27 Bergstrom Donald A (President, R&D) Sale 976 22.73 22,184
2022-09-27 Adams Brian (Chief Legal Officer) Sale 294 22.73 6,682
2022-09-15 Patel Sanjiv (President and CEO) Sale 14,000 23.80 333,200
2022-09-15 Patel Sanjiv (President and CEO) Option Ex 14,000 4.12 57,680
2022-09-14 Patel Sanjiv (President and CEO) Sale 14,000 23.47 328,580
2022-09-14 Patel Sanjiv (President and CEO) Option Ex 14,000 4.12 57,680
2022-09-13 Patel Sanjiv (President and CEO) Sale 14,000 25.45 356,300
2022-09-13 Patel Sanjiv (President and CEO) Option Ex 14,000 4.12 57,680
2022-09-08 Catinazzo Thomas (Chief Financial Officer) Sale 26,257 30.00 787,710
2022-09-08 Catinazzo Thomas (Chief Financial Officer) Option Ex 26,257 4.12 108,178
2022-09-08 Murcko Mark (Director) Sale 25,000 29.95 748,750
2022-09-08 Bergstrom Donald A (President, R&D) Sale 25,000 30.00 750,000
2022-09-08 Bergstrom Donald A (President, R&D) Option Ex 25,000 4.12 103,000
2022-09-02 Bergstrom Donald A (President, R&D) Sale 4,900 25.46 124,754
2022-09-02 Bergstrom Donald A (President, R&D) Option Ex 4,900 4.12 20,188
2022-09-01 Bergstrom Donald A (President, R&D) Sale 8,100 23.07 186,867
2022-09-01 Bergstrom Donald A (President, R&D) Option Ex 8,100 4.12 33,372
2022-08-24 Bergstrom Donald A (President, R&D) Sale 15,000 25.00 375,000
2022-08-24 Bergstrom Donald A (President, R&D) Option Ex 15,000 4.12 61,800
2022-08-05 Bergstrom Donald A (President, R&D) Sale 8,000 20.00 160,000
2022-08-05 Bergstrom Donald A (President, R&D) Option Ex 8,000 4.12 32,960
2022-07-28 Porter Andy (Chief Administrative Officer) Sale 452 21.27 9,614
2022-07-28 Catinazzo Thomas (Chief Financial Officer) Sale 734 21.26 15,604
2022-07-28 Bergstrom Donald A (President, R&D) Sale 1,835 21.27 39,030
2022-07-28 Adams Brian (Chief Legal Officer) Sale 734 21.27 15,612
2022-07-06 Bergstrom Donald A (President, R&D) Sale 8,000 20.00 160,000
2022-07-06 Bergstrom Donald A (President, R&D) Option Ex 8,000 4.12 32,960
2022-06-27 Porter Andy (Chief Administrative Officer) Sale 265 20.31 5,382
2022-06-27 Catinazzo Thomas (Chief Financial Officer) Sale 300 20.31 6,093
2022-06-27 Bergstrom Donald A (President, R&D) Sale 999 20.31 20,289
2022-06-27 Adams Brian (Chief Legal Officer) Sale 300 20.31 6,093
2022-06-24 Bergstrom Donald A (President, R&D) Sale 8,000 20.00 160,000
2022-06-24 Bergstrom Donald A (President, R&D) Option Ex 8,000 4.12 32,960
2022-05-02 Bergstrom Donald A (President, R&D) Sale 13,000 24.62 320,060
2022-05-02 Bergstrom Donald A (President, R&D) Option Ex 13,000 4.12 53,560
2022-04-28 Porter Andy (Chief Administrative Officer) Sale 435 25.57 11,122
2022-04-28 Catinazzo Thomas (Chief Financial Officer) Sale 725 25.57 18,538
2022-04-28 Bergstrom Donald A (President, R&D) Sale 1,811 25.57 46,307
2022-04-28 Adams Brian (Chief Legal Officer) Sale 708 25.57 18,103
2022-04-14 Patel Sanjiv (President and CEO) Sale 28,000 30.51 854,280
2022-04-14 Patel Sanjiv (President and CEO) Option Ex 28,000 4.58 128,240
2022-04-13 Patel Sanjiv (President and CEO) Sale 28,000 31.95 894,600
2022-04-13 Patel Sanjiv (President and CEO) Option Ex 28,000 4.58 128,240
2022-04-12 Patel Sanjiv (President and CEO) Sale 28,000 31.80 890,400
2022-04-12 Patel Sanjiv (President and CEO) Option Ex 28,000 4.12 115,360
2022-04-01 Bergstrom Donald A (President, R&D) Sale 18,000 30.32 545,760
2022-04-01 Bergstrom Donald A (President, R&D) Option Ex 18,000 4.12 74,160
2022-03-29 Catinazzo Thomas (Chief Financial Officer) Sale 282 29.87 8,423
2022-03-29 Bergstrom Donald A (President, R&D) Sale 622 29.87 18,579
2022-03-29 Adams Brian (Chief Legal Officer) Sale 333 29.87 9,946
2022-03-24 Catinazzo Thomas (Chief Financial Officer) Sale 13,286 30.00 398,580
2022-03-24 Catinazzo Thomas (Chief Financial Officer) Option Ex 13,286 4.12 54,738
2022-03-24 Bergstrom Donald A (President, R&D) Sale 10,000 30.00 300,000
2022-03-24 Bergstrom Donald A (President, R&D) Option Ex 10,000 4.12 41,200
2022-03-10 Bergstrom Donald A (President, R&D) Sale 10,000 25.00 250,000
2022-03-10 Bergstrom Donald A (President, R&D) Option Ex 10,000 4.12 41,200
2022-03-01 Bergstrom Donald A (President, R&D) Sale 8,000 23.88 191,040
2022-03-01 Bergstrom Donald A (President, R&D) Option Ex 8,000 4.12 32,960
2022-02-22 Bergstrom Donald A (President, R&D) Sale 22,994 20.95 481,724
2022-02-22 Bergstrom Donald A (President, R&D) Option Ex 8,000 4.12 32,960
2021-12-27 Porter Andy (See Remarks) Sale 260 33.10 8,606
2021-12-27 Catinazzo Thomas (Senior Vice President, Finance) Sale 295 33.10 9,764
2021-12-27 Bergstrom Donald A (See Remarks) Sale 649 33.10 21,481
2021-12-27 Adams Brian (General Counsel) Sale 295 33.10 9,764
2021-11-15 Catinazzo Thomas (Senior Vice President, Finance) Sale 22,500 35.40 796,500
2021-11-15 Catinazzo Thomas (Senior Vice President, Finance) Option Ex 22,500 4.12 92,700
2021-11-15 Adams Brian (General Counsel) Sale 6,500 35.42 230,230
2021-11-15 Adams Brian (General Counsel) Option Ex 6,500 4.12 26,780
2021-10-15 Bergstrom Donald A (See Remarks) Sale 30,000 34.15 1,024,500
2021-09-27 Catinazzo Thomas (Senior Vice President, Finance) Sale 293 36.87 10,802
2021-09-27 Bergstrom Donald A (See Remarks) Sale 646 36.87 23,818
2021-09-27 Adams Brian (General Counsel) Sale 293 36.87 10,802
2021-09-13 Catinazzo Thomas (Senior Vice President, Finance) Sale 22,500 35.00 787,500
2021-09-13 Catinazzo Thomas (Senior Vice President, Finance) Option Ex 22,500 4.12 92,700
2021-09-13 Adams Brian (General Counsel) Sale 6,500 35.02 227,630
2021-09-13 Adams Brian (General Counsel) Option Ex 6,500 4.12 26,780
2021-06-28 Bergstrom Donald A (See Remarks) Sale 976 35.81 34,950
2021-06-16 Bergstrom Donald A (See Remarks) Sale 42,242 33.75 1,425,667
2021-06-16 Bergstrom Donald A (See Remarks) Option Ex 42,242 4.12 174,037
2021-06-07 Catinazzo Thomas (Senior Vice President, Finance) Sale 22,500 35.00 787,500
2021-06-07 Catinazzo Thomas (Senior Vice President, Finance) Option Ex 22,500 4.12 92,700
2021-06-07 Adams Brian (General Counsel) Sale 6,500 35.00 227,500
2021-06-07 Adams Brian (General Counsel) Option Ex 6,500 4.12 26,780
2021-04-26 Adams Brian (General Counsel) Sale 6,500 35.00 227,500
2021-04-26 Adams Brian (General Counsel) Option Ex 6,500 4.12 26,780
2021-03-30 Catinazzo Thomas (Senior Vice President, Finance) Sale 22,500 35.00 787,500
2021-03-30 Catinazzo Thomas (Senior Vice President, Finance) Option Ex 22,500 4.12 92,700
2021-01-28 Adams Brian (General Counsel) Sale 5,000 55.05 275,250
2021-01-28 Adams Brian (General Counsel) Option Ex 5,000 4.12 20,600
2021-01-14 Trv Gp Iv, Llc (10% Owner) Sale 1,965,294 41.00 80,577,054
2021-01-13 Trv Gp Iv, Llc (10% Owner) Sale 2,157,100 42.39 91,435,154
2021-01-12 Trv Gp Iv, Llc (10% Owner) Sale 1,500,000 40.00 60,000,000
2020-07-20 Rubin Jami (Director) Buy 25,000 20.00 500,000
2020-07-20 Patel Sanjiv (President and CEO) Buy 25,000 20.00 500,000
2020-07-20 Murcko Mark (Director) Buy 25,000 20.00 500,000
2020-07-20 Adams Brian (General Counsel) Buy 10,000 20.00 200,000
2020-07-20 Ingram Douglas S (Director) Buy 25,000 20.00 500,000
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of RLAY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Relay Therapeutics, Inc. (symbol RLAY, CIK number 1812364) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.